Z-Arg(NO2)-OHCAS# 2304-98-5 |
- Fulvestrant
Catalog No.:BCC1081
CAS No.:129453-61-8
- Bazedoxifene
Catalog No.:BCC1411
CAS No.:198481-32-2
- Bazedoxifene acetate
Catalog No.:BCC1412
CAS No.:198481-33-3
- (E)-2-Decenoic acid
Catalog No.:BCC1292
CAS No.:334-49-6
- Toremifene
Catalog No.:BCC2010
CAS No.:89778-26-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 2304-98-5 | SDF | Download SDF |
PubChem ID | 102781 | Appearance | Powder |
Formula | C14H19N5O6 | M.Wt | 353.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Z-Arg(NO2)-OH; 2304-98-5; Z-L-Arg(NO2)-OH; N-cbz-n-nitro-l-arginine | ||
Solubility | Soluble in water or 1% acetic acid | ||
Chemical Name | 5-[[amino(nitramido)methylidene]amino]-2-(phenylmethoxycarbonylamino)pentanoic acid | ||
SMILES | C1=CC=C(C=C1)COC(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)O | ||
Standard InChIKey | BZPCSFNCKORLQG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H19N5O6/c15-13(18-19(23)24)16-8-4-7-11(12(20)21)17-14(22)25-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,17,22)(H,20,21)(H3,15,16,18) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Z-Arg(NO2)-OH Dilution Calculator
Z-Arg(NO2)-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8305 mL | 14.1523 mL | 28.3046 mL | 56.6091 mL | 70.7614 mL |
5 mM | 0.5661 mL | 2.8305 mL | 5.6609 mL | 11.3218 mL | 14.1523 mL |
10 mM | 0.283 mL | 1.4152 mL | 2.8305 mL | 5.6609 mL | 7.0761 mL |
50 mM | 0.0566 mL | 0.283 mL | 0.5661 mL | 1.1322 mL | 1.4152 mL |
100 mM | 0.0283 mL | 0.1415 mL | 0.283 mL | 0.5661 mL | 0.7076 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Z-Arg(NO2)-OH
- Z-Asn-OH
Catalog No.:BCC2794
CAS No.:2304-96-3
- Z-β-Ala-OH
Catalog No.:BCC3058
CAS No.:2304-94-1
- Terbutaline Sulfate
Catalog No.:BCC4320
CAS No.:23031-32-5
- Apelin-36 (rat, mouse)
Catalog No.:BCC5911
CAS No.:230299-95-3
- Physalin A
Catalog No.:BCN7920
CAS No.:23027-91-0
- Neoglycyrol
Catalog No.:BCN2907
CAS No.:23013-84-5
- MPTP hydrochloride
Catalog No.:BCC1778
CAS No.:23007-85-4
- Atazanavir sulfate (BMS-232632-05)
Catalog No.:BCC2114
CAS No.:229975-97-7
- AGN 194310
Catalog No.:BCC5416
CAS No.:229961-45-9
- GW9662
Catalog No.:BCC2260
CAS No.:22978-25-2
- Abn-CBD
Catalog No.:BCC7011
CAS No.:22972-55-0
- Desmethoxycentaureidin
Catalog No.:BCN5077
CAS No.:22934-99-2
- Ajugasterone C
Catalog No.:BCN2757
CAS No.:23044-80-6
- Lofepramine
Catalog No.:BCC7402
CAS No.:23047-25-8
- Dihydroconiferyl alcohol
Catalog No.:BCN7047
CAS No.:2305-13-7
- L-AP4
Catalog No.:BCC6550
CAS No.:23052-81-5
- (-)-Sophoranone
Catalog No.:BCN7162
CAS No.:23057-55-8
- Sinensetin
Catalog No.:BCN6356
CAS No.:2306-27-6
- Varenicline Hydrochloride
Catalog No.:BCC4156
CAS No.:230615-23-3
- Eurycomalactone
Catalog No.:BCN3108
CAS No.:23062-24-0
- PD 102807
Catalog No.:BCC7145
CAS No.:23062-91-1
- 4-Amino-N-methylphthalimide
Catalog No.:BCC8686
CAS No.:2307-00-8
- Xylazine HCl
Catalog No.:BCC4341
CAS No.:23076-35-9
- Sitosteryl palmitate
Catalog No.:BCN5078
CAS No.:2308-85-2
Studies on lactam formation during coupling procedures of N alpha-N omega-protected arginine derivatives.[Pubmed:8738983]
Pept Res. 1996 Mar-Apr;9(2):88-91.
We evaluated the quantity of delta-lactam generated during the synthesis of arginine-containing dipeptides using Z-Arg(Tos)-OH, Boc-Arg(Tos)-OH, Fmoc-Arg(Boc)2-OH and Fmoc-Arg(Pmc)-OH and assayed several carboxyl-activating procedures for coupling the protected arginines to different amino components. We observed significant amounts of delta-lactam during the synthesis of Z-Arg(Tos)-methyl ester and Z-Arg(Tos)-amide, as well as of Boc-Arg(Tos)-chloromethyl ketone. The mixed anhydride coupling procedure and the di-Boc-protecting guanidino group induced more delta-lactam formation than any other coupling or NG-protection method. The amide, benzyl, 4-(NO2)-benzyl and methyl alpha-carboxyl-protected amino acids generated more delta-lactam than did those protected by tertbutyl or N2H2-Boc. So far it has not been possible to propose a general mechanism for delta-lactam formation or a process that completely abolishes it. Therefore, this side reaction should be considered almost inevitable. Its minimization requires examination of arginine-containing peptides in each specific synthesis.